Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center Faculty Position– Division of Hematologic Malignancies, Department of Medical Oncology

Job Details

The Department of Medical Oncology at Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center (SKCCC), seeks highly qualified academic physicians in Hematology or Medical Oncology to join the Division of Hematologic Malignancies. Candidates must possess an M.D., or D.O. degree, must be BE/BE in Hematology and/or Medical Oncology, and be eligible for a medical license in Pennsylvania. 

Job Description

The ideal candidate will be an outstanding disease-focused academic physician at either the Assistant Professor or Associate Professor rank. The ideal candidate will have a strong focus and some prior experience in clinical research in lymphoma as well as Transplant and Cellular Therapies (TCT’s), and potential to build a national reputation as an independent investigator and leader in clinical research. Experience in translational research is of additional interest, but not required. An interest in education and an early track record of mentoring of trainees are also welcome. There is also potential opportunity within this position for Leadership in the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Clinical Trials Office (CTO) as Medical Director.

The Division of Hematologic Malignancies, based in center city Philadelphia, comprises faculty that are recognized for excellence in the triple mission of patient care, research and training. Every year, Division faculty and nurses provide complex multidisciplinary and personalized care to hundreds patients with all types of hematologic malignancies, including rare and highly complex blood cancers, attracting referrals nationally and internationally.

The Division is a national leader in the development of new therapies for blood cancers, with a pipeline of clinical trials that is managed by a disease-specific (Lymphoma, Myeloma, and Leukemia/MDS) and a modality-specific (BMT/CART) multidisciplinary disease group (MDG) and includes CART- and CAR-NK cell therapies, molecularly targeted therapies, and novel immunotherapies. The Division’s clinical trial portfolio is further enhanced by an outstanding Phase I program, in academic partnership with the Sarah Cannon Research Institute (SCRI), and a strong and innovative Health Delivery Research group.

The SKCCC is an NCI Comprehensive Cancer Center that includes researchers from Thomas Jefferson University and Drexel University and offers outstanding shared core facilities. The SKCCC is located in the heart of Philadelphia, a vibrant urban cultural scene with an abundance of opportunities for professional and social interactions.  Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.

Interested individuals should forward their CV as well as a cover letter describing their interests, and the names of three references to: Margaret Kasner, MD, Interim Director, Division of Hematologic Malignancies, Department of Medical Oncology, c/o Steven Dawson, Thomas Jefferson University, 834 Chestnut Street, Suite 320, Philadelphia, PA  19107: (email: Steven.Dawson@jefferson.edu)

Work Shift

Workday Day (United States of America)

Worker Sub Type

Regular

Employee Entity

Thomas Jefferson University

Primary Location Address

100 S 9th Street, Philadelphia, Pennsylvania, United States of America

Nationally ranked, Jefferson, which is principally located in the greater Philadelphia region, Lehigh Valley and Northeastern Pennsylvania and southern New Jersey, is reimagining health care and higher education to create unparalleled value. Jefferson is more than 65,000 people strong, dedicated to providing the highest-quality, compassionate clinical care for patients; making our communities healthier and stronger; preparing tomorrow's professional leaders for 21st-century careers; and creating new knowledge through basic/programmatic, clinical and applied research.